Comparison Between Liquid-Based Cytology And Molecular Screening For Detecting Precursor Lesions and Cervical Cancer
Recruiting
N/A
Interventional Study
I) Atypical Squamous Cells of Undetermined Significance (ASC-US)
II) Atypical Glandular Cells of Uncertain Significance (AGUS)
III) Cervical Intraepithelial Neoplasia (CIN), CIN-1, CIN-2, CIN-3
IV) Low-grade Squamous Intraepithelial Lesion (LSIL)
V) High-grade Squamous Intraepithelial Lesion (HSIL)
VI) Cervical Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 85
- Sex
- Female
- Study type
- Interventional
- Purpose
- Screening
- Participants needed
- 558 (estimated)
- Sponsor
- Timser SAPI de CV · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study compares how effective is the molecular screening (a blood test) using Pap smear as reference, that is, a comparison of these tests abilities to detect precursor lesions and cervical cancer among women of an open population
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Be in good general health.
* Age 18-85 years.
* A minimum fast of 6 hours and no more than 12 hours.
* Refrain from sexual intercourse 24 hours before the study.
* Give written informed consent.
Exclusion Criteria:
* Having a subtotal, total, or radical hysterectomy.
* Being…
Contacts
Mercedes Gutiérrez-Smith, Bachelor of Arts in History
+52-55-9057-1000
CONTACT